In a strategic move aimed at enhancing financial efficiency, Dallah Health Services has announced the signing of a binding agreement to sell its entire stake of approximately 31.21% in Dr. Mohammed bin Rashid Al-Faqih and Partners. The transaction is in favor of Dr. Suleiman Abdul Qader Al-Faqih Hospital, for a total of 497.9 million Riyals in cash.
Dallah Health clarified that the deal remains subject to several preconditions, the most notable of which is obtaining the approval of the General Authority for Competition, in addition to approvals from some contracting parties with the targeted company. The company also confirmed that there are no regulatory or legal obstacles that could hinder the completion of the transaction.
Details of the Transaction
Dallah Health confirmed that the expected financial impact of the deal will be positive on its financial results during the period in which the transaction is completed. It noted that the targeted company is still in the expansion phase and currently contributes only a limited amount to the group's profitability. The company also indicated that it intends to use the proceeds from the sale primarily to pay off part of its existing Murabaha facilities.
Despite the signing of the agreement, Dallah Health emphasized that this does not mean the deal is finalized, as it will announce any significant developments later in accordance with relevant laws and regulations.
Background & Context
Dallah Health Services is considered one of the leading companies in the healthcare sector in the Kingdom of Saudi Arabia, offering a variety of health services. This step is part of the company's strategy to strengthen its financial position and improve its operational efficiency.
It is worth noting that Dr. Mohammed bin Rashid Al-Faqih and Partners is a startup in the healthcare sector, aiming to expand its range of services and increase its market share. The transaction comes at a time when the healthcare sector in the Kingdom is witnessing significant growth, reflecting companies' interest in enhancing their investments in this field.
Impact & Consequences
This transaction is expected to positively impact Dallah Health, as it will help improve its financial liquidity and alleviate current financial burdens. Additionally, the deal may open new avenues for collaboration among companies in the healthcare sector, enhancing investment opportunities in this vital sector.
This move also serves as an indicator of the general trend in the Saudi market towards focusing on financial efficiency and enhancing investments in startups, reflecting the Kingdom's Vision 2030 aimed at developing the private sector and increasing its contribution to the national economy.
Regional Significance
This transaction aligns with broader trends in the Arab region towards enhancing investments in the healthcare sector, especially in light of the challenges facing health systems in many countries. The deal also underscores the importance of collaboration between large and small companies in achieving sustainable growth.
In conclusion, this transaction represents an important step for Dallah Health, reflecting its strategy to improve financial performance and strengthen its market position. This move is expected to contribute to driving growth in the healthcare sector in the Kingdom.